Stock IDXX IDEXX LABORATORIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News IDEXX Laboratories, Inc.

Equities

IDXX

US45168D1046

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX
Other stock markets
 10:33:57 2024-09-20 am EDT 		5-day change 1st Jan Change
511.87 USD -1.00% Intraday chart for IDEXX Laboratories, Inc. +1.86% -8.15%
Sep. 04 IDEXX Laboratories, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-04-2024 11:30 AM
Aug. 15 IDEXX Laboratories, Inc. - Analyst/Investor Day

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
IDEXX Laboratories, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-04-2024 11:30 AM
IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
BU
IDEXX Laboratories, Inc. - Analyst/Investor Day
Piper Sandler Adjusts Price Target on IDEXX Laboratories to $520 From $600
MT
BNP Paribas Exane Adjusts Price Target on IDEXX Laboratories to $607 From $641
MT
Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999.
CI
IDEXX Laboratories, Inc., Q2 2024 Earnings Call, Aug 06, 2024
IDEXX Labs cuts annual forecast as vet visits remain slow
RE
IDEXX Laboratories Q2 Adjusted Earnings, Revenue Rise; Lowers 2024 Revenue Guidance
MT
IDEXX Laboratories : Q2 2024 Earnings Snapshot
PU
Earnings Flash (IDXX) IDEXX LABORATORIES Reports Q2 Revenue $1B, vs. Street Est of $1B
MT
Idexx: Q2 Earnings Snapshot
AQ
IDEXX Laboratories Announces Second Quarter Results
BU
IDEXX Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
CI
IDEXX Laboratories, Inc. Revises Earnings Guidance for the Year 2024
CI
IDEXX Laboratories Announces Time Change for 2024 Second Quarter Financial Results Conference Call
BU
IDEXX Releases 2023 Corporate Responsibility Report, Highlighting Progress Against Its Goals
PR
BTIG Starts IDEXX Laboratories With Buy Rating, $580 Price Target
MT
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $589 From $596, Maintains Overweight Rating
MT
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IDXX Stock
  4. News IDEXX Laboratories, Inc.